Literature DB >> 121116

Host defenses in experimental scrub typhus: role of normal and activated macrophages.

C A Nacy, J V Osterman.   

Abstract

Resident peritoneal macrophage from BALB/c mice were infected in vitro with Rickettsia tsutsugamushi strain Gilliam, and rickettsial growth was estimated by microscopic examination of Giemsa-stained cells. Both number of infected macrophage per culture and number of intracellular rickettsiae per cell increased with time during culture. Treatment of rickettsiae with immune serum before infection macrophage cultures reduced the number of infected macrophage by 50%. Macrophage treated in vitro with lymphokines were able to suppress rickettsial growth in the absence of detectable antibody and exhibited a 75% reduction in infection compared with normal macrophage. We also obtained activated macrophage from immune mice and found that they were refractory to in vitro rickettsial infection. Macrophage populations activated in vitro or in vivo contained a small percentage of cells which supported unrestrained growth of rickettsiae. These data suggest that an early immunological event in experimental scrub typhus infection may be the development of activated macrophage capable of suppressing rickettsial proliferation before the appearance of circulating antibody.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 121116      PMCID: PMC414677          DOI: 10.1128/iai.26.2.744-750.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Antibacterial product of peritoneal exudate cell cultures from guinea pigs infected with mycobacteria, listeriae, and rickettsiae.

Authors:  S D Sharma; G Middlebrook
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

2.  Serological diagnosis of scrub typhus by indirect immunofluorescence.

Authors:  F M BOZEMAN; B L ELISBERG
Journal:  Proc Soc Exp Biol Med       Date:  1963-03

3.  ELECTRON MICROSCOPICAL OBSERVATIONS ON THE PERITONEAL MACROPHAGES OF NORMAL MICE AND MICE IMMUNISED WITH LISTERIA MONOCYTOGENES. I. STRUCTURE OF NORMAL MACROPHAGES AND THE EARLY CYTOPLASMIC RESPONSE TO THE PRESENCE OF INGESTED BACTERIA.

Authors:  R J NORTH; G B MACKANESS
Journal:  Br J Exp Pathol       Date:  1963-12

4.  Persistence of Rickettsia tsutsugamushi in tissues of patients recovered from scrub typhus.

Authors:  J E SMADEL; H L LEY; R H DIERCKS; J A P CAMERON
Journal:  Am J Hyg       Date:  1952-11

5.  Plaque assay and cloning of scrub typhus rickettsiae in irradiated L-929 cells.

Authors:  S C Oaks; J V Osterman; F M Hetrick
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

6.  Host defenses in experimental scrub typhus: role of cellular immunity in heterologous protection.

Authors:  A Shirai; P J Catanzaro; S M Phillips; J V Osterman
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Host defenses in experimental scrub typhus: histopathological correlates.

Authors:  P J Catanzaro; A Shirai; P K Hilderbrandt; J V Osterman
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

8.  Assessment in vitro of immunity against Toxoplasma gondii.

Authors:  T C Jones; L Len; J G Hirsch
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

9.  Cellular resistance to infection.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

10.  Study on growth of Rickettsia. V. Penetration of Rickettsia tsutsugamushi into mammalian cells in vitro.

Authors:  Z A COHN; F M BOZEMAN; J M CAMPBELL; J W HUMPHRIES; T K SAWYER
Journal:  J Exp Med       Date:  1959-03-01       Impact factor: 14.307

View more
  28 in total

Review 1.  Unresolved problems related to scrub typhus: a seriously neglected life-threatening disease.

Authors:  Daniel H Paris; Thomas R Shelite; Nicholas P Day; David H Walker
Journal:  Am J Trop Med Hyg       Date:  2013-08       Impact factor: 2.345

2.  Neutralization of lymphokine-mediated antirickettsial activity of fibroblasts and macrophages with monoclonal antibody specific for murine interferon gamma.

Authors:  T R Jerrells; J Turco; H H Winkler; G L Spitalny
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  Development of specific and cross-reactive lymphocyte proliferative responses during chronic immunizing infections with Rickettsia tsutsugamushi.

Authors:  T R Jerrells; J V Osterman
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

4.  Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines.

Authors:  O G Baca; E T Akporiaye; A S Aragon; I L Martinez; M V Robles; N L Warner
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

5.  Macrophages in resistance to rickettsial infection: strains of mice susceptible to the lethal effects of Rickettsia akari show defective macrophage Rickettsicidal activity in vitro.

Authors:  C A Nacy; M S Meltzer
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Effect of mouse lymphokines and cloned mouse interferon-gamma on the interaction of Rickettsia prowazekii with mouse macrophage-like RAW264.7 cells.

Authors:  J Turco; H H Winkler
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

7.  Role of macrophages in innate and acquired host resistance to experimental scrub typhus infection of inbred mice.

Authors:  T R Jerrells; J V Osterman
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

8.  Susceptibility of Rickettsia tsutsugamushi Gilliam to gamma interferon in cultured mouse cells.

Authors:  B Hanson
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  Susceptibility of inbred mice to rickettsiae of the spotted fever group.

Authors:  C S Eisemann; M J Nypaver; J V Osterman
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Host defenses in experimental scrub typhus: delayed-type hypersensitivity responses of inbred mice.

Authors:  T R Jerrells; J V Osterman
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.